The Gross Margin of Kaken Pharmaceutical Co Ltd (4521.T) is 53.49%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-03-31 | 53.49% |
| 2023-03-31 | 54.20% |
| 2022-03-31 | 54.68% |
| 2021-03-31 | 54.56% |
| 2020-03-31 | 56.57% |
| 2019-03-31 | 57.13% |
| 2018-03-31 | 56.92% |
| 2017-03-31 | 56.11% |
| 2016-03-31 | 56.64% |
| 2015-03-31 | 52.33% |